AVANDAMET contains 2 oral antidiabetic drugs: rosiglitazone maleate and metformin hydrochloride indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Metformin hydrochloride tablets are indicated for the management of type 2 diabetes mellitus (non-insulin dependent, NIDDM) as monotherapy when hyperglycemia cannot be managed with diet and exercise alone
Metformin Hydrochloride is a biguanide antidiabetic. Glucomet® is given orally for the treatment of type 2 diabetes mellitus. Glucomet® does not stimulate insulin release and requires that some insulin be present in order to exert its antidiabetic effects.
Metfil can be given alone as initial therapy or can be administered in combination with a sulphonylurea